Copenhagen, Denmark
Onsite/Online

ESTRO 2022

Session Item

Tuesday
May 10
09:15 - 10:30
Room D5
Modelling of complex systems and interactions
Charlotte Robert, France;
René Winter, Norway
Modelling is playing an increasing role in the implementation of personalized radiotherapy at a key time when maximizing the immune response is sought. In this session, Pr. R. Mohan will present innovative work based on advanced statistical and machine learning techniques to identify causal factors of radiation-induced lymphopenia, with the ultimate goal to develop "personalized" models predicting the risk of radiation-induced lymphopenia. Complementarily, Pr. C. Grassberger will summarize research on dynamic blood flow modelling to decipher the role of irradiation of the circulating blood in explaining radiation-induced lymphopenia. Work on mathematical modelling of tumor responses in combined immunotherapy/radiotherapy regimens and to oncogene-targeted agents will also be presented. The final presentation, by Pr. I. Toma-Dasu, will focus on dynamic modelling of tumor oxygenation and its application to tumor control predictions. A brief overview of tumor re-oxygenation modelling based on functional imaging of tumor hypoxia will close the session
Symposium
Physics
09:40 - 10:05
Mathematical Modeling of Combined Treatments for Sequencing and Scheduling Optimisation
Clemens Grassberger, USA
SP-0985

Abstract

Mathematical Modeling of Combined Treatments for Sequencing and Scheduling Optimisation
Authors:

Clemens Grassberger1

1Harvard Medical School / Massachusetts General Hospital, Radiation Oncology, Boston, USA

Show Affiliations
Abstract Text

Mathematical modeling has played an important role in developing hypotheses to be tested in clinical trials using radiation therapy and for optimizing their design. Especially in the area of accelerated fractionation and hypofractionation, radiobiological models have played a central role in trial design and estimating the therapeutic benefit of different treatment approaches.

However, the increasing complexity of treatment regimen and the use of biological agents in combination with radiotherapy have emphad the need for approaches encompassing the entire treatment, not only the radiotherapy.

In this talk we will introduce available tools to perform dynamic simulations of blood flow to investigate radiation-induced lymphocyte depletion and its dependence on fractionation and dose rate. Furthermore we will discuss available mathematical frameworks for modeling immunotherapy - radiotherapy combination regimen and resistance development to oncogene-targeted agents.